Literature DB >> 33956281

A rare case of non-traumatic spinal epidural hematoma in lumbar region associated with apixaban therapy.

Petr Krupa1,2, Martin Kanta3, Tomas Hosszu3, Jiri Soukup4, Pavel Ryska5, Petr Dulicek6, Tomas Cesak3.   

Abstract

Spontaneous spinal epidural hematoma (SSEH) is a very rare clinical entity with potential diagnostic difficulties and which can result in severe neurological deficit. The etiology of this rare condition is largely not known, but with potential predisposition in patients on anticoagulation medication. This includes the novel anticoagulants with direct inhibition of the factor Xa mechanism (DOACs). These medications are supposed to have more predictable pharmacokinetics with fewer severe haemorrhagic adverse events in comparison with standard warfarin therapy. However, in the last few years, an increasing number of case reports have been published of haemorrhage into the central nervous system. We present a case of non-traumatic spinal epidural hematoma in the lumbar region in a patient on chronic apixaban therapy. To the best of our knowledge, it is the first described SSEH in the lumbar region associated with apixaban therapy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anticoagulation; Apixaban; Non-traumatic spinal epidural hematoma; Novel oral anticoagulants

Mesh:

Substances:

Year:  2021        PMID: 33956281     DOI: 10.1007/s11239-021-02462-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  2 in total

1.  Spontaneous Spinal Epidural Hematoma in a Patient on Apixaban for Nonvalvular Atrial Fibrillation.

Authors:  Ahmad El Alayli; Logeswari Neelakandan; Hicham Krayem
Journal:  Case Rep Hematol       Date:  2020-04-14

2.  Spontaneous Spinal Epidural Hematoma Associated With Apixaban Therapy: A Report of two Cases.

Authors:  Frank M Mezzacappa; Daniel Surdell; William Thorell
Journal:  Cureus       Date:  2020-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.